In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective αIA receptor antagonists for the treatment of benign prostatic hyperplasia

J. C. Barrow, P. G. Nantermet, H. G. Selnick, K. L. Glass, K. Rittle, K. F. Gilbert, D. J. Triggle

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective αIA receptor antagonists for the treatment of benign prostatic hyperplasia'. Together they form a unique fingerprint.